Author

Edward M. Greenfield

University Hospitals of ClevelandORCID 0000-0002-0921-983XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

Alyssa L. WalkeriD· 1 shared Christopher D. CollieriD· 1 shared Christopher M. FulkersoniD· 1 shared Deep A. GandhiiD· 1 shared Emily E. SeideniD· 1 shared Gabrielle J. KnafleriD· 1 shared Gavin P. Kinsella· 1 shared James D. BuschbachiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alyssa L. WalkerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 22, 2025

Repurposing Romidepsin for Osteosarcoma: Screening FDA-Approved Oncology Drugs with Three-Dimensional Osteosarcoma Spheroids

Emily E. Seiden, Spencer M. Richardson, Leah A. Everitt…·Edward M. Greenfield

This paper identifies romidepsin as a promising repurposed drug for osteosarcoma using 3D spheroid models, showing efficacy against metastatic cells and outperforming other HDIs.

1 citation

humannon-human primate

𝕏 PostBluesky